P0860 Long-term outcomes of extended versus conventional adalimumab dose interval for patients with Crohn’s disease in stable remission: 3-year follow-up of the randomized controlled LADI trialMartine Devillers, Frank Hoentjen, Robbart van Linschoten et al.|Journal of Crohn s and Colitis|2025Cited by 0